About Gary Glick
Gary Glick is an officer and director at Odyssey Therapeutics.
Gary Glick reports to the SEC as a director or officer of 1 public company.
Gary Glick first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Gary Glick in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gary Glick works with at each company, as listed on that company's latest Form D.
Odyssey Therapeutics, Inc. · Form D, Dec 4, 2025
VO
Valerie Odegard
Director
CG
Carl Gordon
Director
CN
Carolyn Ng
Director
TW
Timothy Walbert
Director
Paulina Hill
Director
NL
Nan Li
Director
JL
Jeffrey Leiden
Director
JH
Jason Haas
CFO
NT
Nia Tatsis
Director
KP
Ksenija Pavletic
Director
SC
Shelley Chu
Director
LS
Lan Smith
Director
JC
Jill Carroll
Director